EndoGastric Solutions Secures $12,000,000 Series B Funding
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=a719fa20-abc9-4a69-a52a-b35ad4d5ea23&Preview=1 -
Date
9/11/2004 -
Company Name
EndoGastric Solutions -
Mailing Address
8210 154th Ave NE Redmond, WA 98052 -
Company Description
EndoGastric Solutions, Inc. (FKA Esophyx) is the pioneer in endoluminal procedures for the treatment of upper gastrointestinal diseases, including gastroesophageal reflux disease (GERD) and obesity. EGS’ mission is to utilize the most current wisdom in gastroenterology and surgery to develop new trans-oral procedures and products to address the largest unmet needs in gastrointestinal diseases. -
Website
http://www.endogastricsolutions.com -
Transaction Type
Venture Equity -
Transaction Amount
$12,000,000 -
Transaction Round
Series B -
Proceeds Purposes
The funds will be used to advance the company’s major program into clinical trials and for general corporate expenditures. -
M&A Terms
-
Venture Investor
MPM Capital -
Venture Investor
Advanced Technology Ventures -
Venture Investor
Foundation Medical Partners
